Companies / Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.

Nasdaq: AUPHCanadaCIK 1600620EDMONTON, Canada
Insider flow · last 90 daysNet buys $12.46M

Financials · FY2025

Revenue$283.06M
Net income$287.20M
Total debt
Cash$179.73M
Diluted EPS$2.07
Shares outstanding133.1M

Ownership

133.1M shares outstanding · as of Aug 5, 2026
12.6%Insiders
Ownership
Insiders12.63%16,801,515
Institutions57.04%75,898,198
Public float30.33%40,351,455

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Tang KevinCEOChief Executive Officer · Director · 10% owner
9.80%13,044,106
Greenleaf PeterCEOChief Executive Officer · Director
1.38%1,840,379
Donley Matthew MaxwellChief Operating Officer
0.51%680,299
Miller Joseph MChief Financial Officer
0.43%576,421
Robertson Stephen P.EVP, General Counsel
0.38%505,861
Keenan GregSVP, Chief Medical Officer
0.12%154,449

Institutional holders 262

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 1, 2026Tang Kevin
CEO
BuyCommon Shares$5.25M+344K
+2.75%
12,838,002
9.65% of shares
high
Feb 27, 2026Tang Kevin
CEO
BuyCommon Shares$4.17M+300K
+2.65%
11,629,500
8.74% of shares
high
May 29, 2026Tang Kevin
CEO
BuyCommon Shares$4.02M+263K
+2.15%
12,494,481
9.39% of shares
high
Jun 2, 2026Tang Kevin
CEO
BuyCommon Shares$3.15M+206K
+1.60%
13,044,106
9.80% of shares
high
Feb 27, 2026Tang Kevin
CEO
BuyCommon Shares$3.03M+215K
+1.85%
11,844,339
8.90% of shares
high
Mar 3, 2026Tang Kevin
CEO
BuyCommon Shares$2.62M+184K
+1.53%
12,229,500
9.19% of shares
high
Jan 2, 2026Greenleaf Peter
CEO
OtherCommon Stock$1.81M-113K
-5.78%
1,845,037
1.39% of shares
low
Mar 2, 2026Tang Kevin
CEO
BuyCommon Shares$1.65M+116K
+0.97%
12,045,292
9.05% of shares
high

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AUPHCommon StockEquity05156V102BBG000BCRJM5